Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

This phase II trial tests whether fisetin works to improve physical function in women who have received chemotherapy for stage I-III breast cancer treatment. Fisetin is a naturally occurring substance that is found in strawberries and other foods. Fisetin eliminates cells that have undergone a process called senescence. Senescence is when a cell ages and permanently stops dividing but does not die. Over time, large numbers of these cells build up in tissues throughout the body and can release harmful substances that causes inflammation and damages nearby healthy cells. Studies have shown that

Trial Details

NCT ID
NCT05595499
Phase
PHASE2
Sponsor
Jonsson Comprehensive Cancer Center
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Biospecimen Collection
  • Fisetin
  • Placebo Administration
  • Quality-of-Life Assessment
  • Questionnaire Administration
Locations (sample)
  • Alhambra, California, United States|34.09529,-118.12701
  • Beverly Hills, California, United States|34.07362,-118.40036
  • Burbank, California, United States|34.18084,-118.30897
  • Duarte, California, United States|34.13945,-117.97729
  • Los Angeles, California, United States|34.05223,-118.24368

Key Eligibility Criteria

  • Women who are postmenopausal at the start of study treatment.
  • Postmenopausal status will be established as follows:
  • Women aged: \>= 60 years OR
  • Women aged \< 60 years AND one of the following conditions is met:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →